Literature DB >> 19927293

Axenfeld-Rieger ocular anomaly and retinoblastoma caused by constitutional chromosome 13q deletion.

Ana Roche1, Jaume Mora, Maria Del Mar Perez, Esther Gean, Belen Perez, Mar O'Callaghan, Jaume Catala, Carmen De Torres, Ofelia Cruz, Joan Prat, Andreu Parareda.   

Abstract

Axenfeld-Rieger (AR) ocular anomaly might be due to deletions of different chromosomes. No association between AR, mental retardation, and retinoblastoma has been described. We report a 2-month-old female with general development delay and dysmorphic features. AR anomaly was detected, and a retinoblastoma (RB) was diagnosed in a very early stage. De novo 13q deletion was identified. Systemic chemotherapy, focal cryotherapy, transpupillary thermotherapy, brachytherapy, and intra-arterial chemotherapy were needed to control the RB. This is the first report of an association of AR, 13q deletion, and retinoblastoma, to be disclosed in patients born with such ocular and dysmorphic features. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 19927293     DOI: 10.1002/pbc.22354

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

Review 1.  Genetics of anterior segment dysgenesis disorders.

Authors:  Linda M Reis; Elena V Semina
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

2.  Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.

Authors:  Lucy V Cobbs; Jasmine H Francis; Ira J Dunkel; Y Pierre Gobin; Scott E Brodie; David H Abramson
Journal:  Pediatr Blood Cancer       Date:  2020-12-23       Impact factor: 3.838

3.  A novel deletion cluster at 13q14.2-q21.33 in an 80-year man with late onset leukemia: Clinical and molecular findings.

Authors:  Kiran Kumar; Sujit Maiti; Christina A Castellani; Richard O'Reilly; Shiva M Singh
Journal:  Indian J Hum Genet       Date:  2013-01

4.  Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome.

Authors:  Alexander B Dillon; Alexzandra Douglass; Pascal Jabbour; Carol L Shields
Journal:  Oman J Ophthalmol       Date:  2016 Sep-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.